Table 5 Adverse events
Placebo | Silymarin | |
|---|---|---|
(N = 28) | (N = 27) | |
Major adverse events | 0 | 0 |
Minor adverse events | 3 (10.7) | 3 (10.7) |
• Nausea / vomiting | 1 | 3 |
• Dizziness | 2 | 0 |
Total | 3 (10.7) | 3 (10.7) |
Placebo | Silymarin | |
|---|---|---|
(N = 28) | (N = 27) | |
Major adverse events | 0 | 0 |
Minor adverse events | 3 (10.7) | 3 (10.7) |
• Nausea / vomiting | 1 | 3 |
• Dizziness | 2 | 0 |
Total | 3 (10.7) | 3 (10.7) |